MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
about
Mcm10: A Dynamic Scaffold at Eukaryotic Replication ForksRETRACTED: Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling.DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast CancerPrognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis
P2860
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@en
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@nl
type
label
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@en
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@nl
prefLabel
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@en
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
@en
P2093
Bi-Wen Yeh
Chien-Feng Li
Ching-Chia Li
Chun-Hsiung Huang
Chun-Nung Huang
Hsin-Chih Yeh
Hung-Lung Ke
Lin-Li Chang
Peir-In Liang
Ti-Chun Chan
P2860
P304
77777-77792
P356
10.18632/ONCOTARGET.12795
P407
P50
P577
2016-10-21T00:00:00Z